Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial

Sponsor
Oslo University Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02939612
Collaborator
Norwegian Cancer Society (Other)
200
1
2
68.9
2.9

Study Details

Study Description

Brief Summary

The purpose with this study is to test the effect of an app for stress management among patients with a variety of cancer diagnoses.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: App for stress management
N/A

Detailed Description

A cancer diagnosis and subsequent treatment can be disruptive and traumatic, often accompanied by a multitude of stressors for the patients and their support network. Uncertainty of outcome and invasive medical procedures with aversive side effects are not uncommon, and while people differ widely in how they experience and cope with such challenges, cancer related distress including anxiety, depression, worry and rumination is prevalent. With multiple domains of function impacted it is also not surprising that quality of life (QoL) often is diminished.

Stress management interventions can facilitate adjustment to cancer, including reduced distress and improved quality of life. Unfortunately, many people with cancer do not have the strength or opportunity to attend groups or in-person interventions.

This study will therefore test the effect of an app for stress management among patients with different cancer diagnosis. The app contains 10 modules distributed over five weeks, focusing on education of different techniques for reduction of stress and stress reduction exercises.

The app was tested in a feasibility pilot study among 25 patients with a variety of cancer diagnoses and is now being tested in a randomized controlled trial with a sample of 175 cancer survivors. The participants were randomly assigned to use the 10 module app or to a control group that receive treatment as usual, and will be followed with repeated measures over 12 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Testing a Computerized Interactive Stress Management Intervention in Early Stage Cancer: A Randomized Controlled Trial
Study Start Date :
Oct 1, 2016
Actual Primary Completion Date :
Aug 1, 2020
Anticipated Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: App for Stress management

Participants will get access to two modules per week for five weeks (total 10 modules). The app consists of stress management education, cognitive behavioral interventions and relaxation training exercises.

Behavioral: App for stress management
An app consisting of 10 modules that teaches stress management, cognitive behavioral coping skills and relaxation training.
Other Names:
  • Stress management
  • No Intervention: Waitlist control group

    Participants will get treatment as usual during the study. After the one year study follow up they will receive the stress management app.

    Outcome Measures

    Primary Outcome Measures

    1. The Perceived Stress Scale (PSS-14) [Baseline, post intervention follow up at 3, 6, and 12 months]

      14 item scale measuring perceived stress. Scale range: 0-56. Higher scores indicate higher perceived stress.

    Secondary Outcome Measures

    1. SF-36 Item Short Form Health Survey (RAND-36 version) [Baseline, post intervention follow up at 3, 6, and 12 months]

      36 item scale measuring health related quality of life (HRQoL). The scale has 8 subscales and 1 single item score. Scale and single item range: 0 to 100. Higher scores indicate higher HRQoL.

    2. The Self-Regulatory Fatigue-18 (SRF-18) [Baseline, post intervention follow up at 3 and 12 months]

      18 item scale measuring self-regulation. Scale range: 18 to 90. A higher score indicates higher self regulatory fatigue

    3. The Brief Coping Orientation to Problems (Brief COPE) [Baseline]

      The outcome measure consists of 14 different scales of different coping strategies with two items per scale, for a total of 28 items. Scale range 2 to 8. Higher scores indicate higer use of the different coping strategies

    4. Health, well-being and sleep [Baseline, post intervention follow up at 3, 6, and 12 months]

      A 5 item measure, measuring health, well-being and sleep on a scale from 0 to 10. Higher scores indicate better health, well-being and sleep

    5. Intervention commentary [Post intervention (immediately post intervention)]

      A six item brief measure of participant's intervention reactions. The first 3 items gauged participants' program perception on a scale from 1 to 5, with 5 indicating better perception. The next 3 items were open ended questions: * What did you like best? * What did you like the least? * Suggestions for improvement?

    6. The Hospital Anxiety and Depression Scale (HADS) [Baseline, post intervention follow up at 3, 6, and 12 months]

      14 item scale measuring anxiety and depression. The Scale has a total score with a scale range of 0 to 42 and an anxiety (HADS-A) and a depression (HADS-D) subscale, both with scale range of 0 to 21. Higer scores indicate higher level of anxiety and depression

    7. The Distress Thermometer [Baseline, post intervention follow up at 3, 6, and 12 months]

      One item scale measuring distress on a scale from 0 to 10. Higer scores indicate higher distress

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients diagnosed with cancer (all diagnosis).

    • Maximum time since completed treatment at hospital: 12 months

    • Patients are > 18 years of age, able to write/read/speak Norwegian and have their own smart phone or tablet

    Exclusion Criteria:

    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Oslo University hospital Oslo Norway

    Sponsors and Collaborators

    • Oslo University Hospital
    • Norwegian Cancer Society

    Investigators

    • Principal Investigator: Lise Solberg Nes, PhD, Oslo University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Lise Solberg Nes, Head of Department, Oslo University Hospital
    ClinicalTrials.gov Identifier:
    NCT02939612
    Other Study ID Numbers:
    • 2016/1436
    First Posted:
    Oct 20, 2016
    Last Update Posted:
    Sep 13, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Lise Solberg Nes, Head of Department, Oslo University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 13, 2021